Concordance of BRCA mutation detection in tumor versus blood, and frequency of bi-allelic loss of BRCA in tumors from patients in the phase III SOLO2 trial.
Gynecol Oncol
; 163(3): 563-568, 2021 12.
Article
in En
| MEDLINE
| ID: mdl-34742578
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Germ-Line Mutation
/
Loss of Heterozygosity
/
BRCA2 Protein
/
Ubiquitin-Protein Ligases
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Gynecol Oncol
Year:
2021
Document type:
Article
Affiliation country:
Estados Unidos